Catasys Inc. (CATS) Rating Lowered to Sell at Zacks Investment Research
Catasys Inc. (OTCMKTS:CATS) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a research report issued to clients and investors on Monday.
According to Zacks, “Catasys, Inc., formerly known as Hythiam, Inc., provides specialized behavioral health management services to health plans, employers and unions through a network of licensed and company managed health care providers. The Company’s program seeks to improve member health by delivering medical and psychosocial interventions in combination with long term care coaching, including their proprietary treatment program for alcoholism and stimulant dependence. Catasys, Inc. is based in Los Angeles. “
Catasys (OTCMKTS:CATS) opened at 1.20 on Monday. The stock’s market capitalization is $66.06 million. Catasys has a 12 month low of $0.25 and a 12 month high of $1.55. The company’s 50-day moving average price is $1.23 and its 200 day moving average price is $0.81.
Catasys (OTCMKTS:CATS) last released its quarterly earnings data on Tuesday, August 16th. The company reported ($0.06) earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.04) by $0.02. On average, analysts forecast that Catasys will post ($0.12) earnings per share for the current fiscal year.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Catasys Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Catasys Inc. and related companies with MarketBeat.com's FREE daily email newsletter.